Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

King Appeals Directly To Alpharma Investors To Clear Buyout

This article was originally published in The Pink Sheet Daily

Executive Summary

New offer gives Alpharma a “go-shop” option to find a better price elsewhere.
Advertisement

Related Content

King’s Dogged Pursuit of Alpharma Comes Up Aces
King’s Dogged Pursuit of Alpharma Comes Up Aces
King’s Higher Bid For Alpharma Still No Ace, Board Says
King’s Higher Bid For Alpharma Still No Ace, Board Says
King’s Bigger Bid Still Too Low, Alpharma Board Says
Alpharma Pain Franchise Adds Durect’s Eladur
Alpharma Ups Ante With Phase III Embeda Proof
Third Time’s Not The Charm For King’s Pursuit of Alpharma
King Makes Play For Alpharma To Build Specialty Pain Franchise
King Makes Play For Alpharma To Build Specialty Pain Franchise

Topics

Advertisement
UsernamePublicRestriction

Register

PS068330

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel